With the rapid pace of immunologic research, it is more important than ever for readers to understand rational immunodiagnosis, immunopro-phylaxis, and immunotherapy. This column is intended to help you ensure proper immunologic drug use in your practice.
Get full access to this article
View all access options for this article.
References
1.
GrabensteinJ.D.Get it in writing: Documenting immunizations. Hosp Pharm.1991; 26: 901–4.
2.
AtkinsonW., FurphyL., GanttJ., May-fieldM., RhyneG., ed. Epidemiology and Prevention of Vaccine-Preventable Diseases.5th ed.Atlanta, GA: Centers for Disease Control and Prevention; 1999.
3.
American College of Physicians. Guide for Adult Immunizations.3rd ed.Philadelphia, PA: American College of Physicians; 1994.
4.
PeterG., ed. 1997 Red Book: Report of the Committee on Infectious Diseases.24th ed.Elk Grove Village, IL: American Academy of Pediatrics; 1997.
5.
Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR.1994; 43(RR-1): 1–38.
GrabensteinJ.D.ImmunoFacts: Vaccines and Immunologic Drugs.Saint Louis, MO: Facts and Comparisons; May 1999.
8.
Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR.1983; 32: 1–17.
9.
Advisory Committee on Immunization Practices. Update on adult immunization: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR.1991; 40(RR-12): 1–94.
10.
Centers for Disease Control and Prevention. Assessing adult vaccination status at age 50 years. MMWR.1995; 44: 561–3.
11.
Advisory Committee on Immunization Practices. Immunization of adolescents. MMWR.1996; 45(RR-13): 1–16.
12.
Centers for Disease Control and Prevention. Recommended childhood immunization schedule—United States, 1999. MMWR.1999; 48: 8–16.
13.
Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States: Introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. MMWR.1997; 46: (RR-3): 1–25; errata 1997;46: 183.
14.
Advisory Committee on Immunization Practices. Update: Vaccine side effects, adverse reactions, contraindications, and precautions. MMWR.1996; 45(RR-12): 1–35; errata 1997;46: 227.
15.
Advisory Committee on Immunization Practices. Recommendations of the Advisory Committee on Immunization Practices: Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR.1993; 42(RR-4): 1–18.
16.
American Academy of Pediatrics. Recommended timing of routine measles immunization for children who have recently received immune globulin preparations. Pediatrics.1994; 93: 682–5.
